Literature DB >> 28194353

Labia Majora Share.

Hanjing Lee1, Yan Lin Yap1, Jeffrey Jen Hui Low2, Jane Lim1.   

Abstract

Defects involving specialised areas with characteristic anatomical features, such as the nipple, upper eyelid, and lip, benefit greatly from the use of sharing procedures. The vulva, a complex 3-dimensional structure, can also be reconstructed through a sharing procedure drawing upon the contralateral vulva. In this report, we present the interesting case of a patient with chronic, massive, localised lymphedema of her left labia majora that was resected in 2011. Five years later, she presented with squamous cell carcinoma over the left vulva region, which is rarely associated with chronic lymphedema. To the best of our knowledge, our management of the radical vulvectomy defect with a labia majora sharing procedure is novel and has not been previously described. The labia major flap presented in this report is a shared flap; that is, a transposition flap based on the dorsal clitoral artery, which has consistent vascular anatomy, making this flap durable and reliable. This procedure epitomises the principle of replacing like with like, does not interfere with leg movement or patient positioning, has minimal donor site morbidity, and preserves other locoregional flap options for future reconstruction. One limitation is the need for a lax contralateral vulva. This labia majora sharing procedure is a viable option in carefully selected patients.

Entities:  

Keywords:  Carcinoma, squamous cell; Lymphedema; Perineum

Year:  2017        PMID: 28194353      PMCID: PMC5300930          DOI: 10.5999/aps.2017.44.1.80

Source DB:  PubMed          Journal:  Arch Plast Surg        ISSN: 2234-6163


  15 in total

1.  Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee.

Authors:  Mario Sideri; Ronald W Jones; Edward J Wilkinson; Mario Preti; Debra S Heller; James Scurry; Hope Haefner; Sallie Neill
Journal:  J Reprod Med       Date:  2005-11       Impact factor: 0.142

2.  Labial reconstruction with a cross-labial flap.

Authors:  Anh T V Nguyen; Alex J Ramsden; Brigid E Corrigan; Morris Ritz
Journal:  J Plast Reconstr Aesthet Surg       Date:  2011-03-05       Impact factor: 2.740

Review 3.  Squamous cell carcinoma in chronic lymphedema: case report and review of the literature.

Authors:  Hiroshi Furukawa; Yuhei Yamamoto; Hidehiko Minakawa; Tsuneki Sugihara
Journal:  Dermatol Surg       Date:  2002-10       Impact factor: 3.398

4.  Two-stage posterior cross-labial transposition flap: a novel technique for labium minus reconstruction.

Authors:  Philip H Zeplin; Rima Nuwayhid; Marwan Nuwayhid
Journal:  Aesthetic Plast Surg       Date:  2014-09-06       Impact factor: 2.326

5.  Reconstruction of acquired perineovulvar defects: a proposal of sequence.

Authors:  J Joris Hage; Marc van Beurden
Journal:  Semin Plast Surg       Date:  2011-05       Impact factor: 2.314

6.  Squamous cell carcinoma of the penis in a patient with chronic isolated penile lymphoedema.

Authors:  P Hadway; M Lynch; C M Corbishley; P S Mortimer; N A Watkin
Journal:  Urol Int       Date:  2006       Impact factor: 2.089

7.  Transformation of the common wart into squamous cell carcinoma in a patient with primary lymphedema.

Authors:  W B Shelley; M G Wood
Journal:  Cancer       Date:  1981-08-01       Impact factor: 6.860

Review 8.  Lymphedema: an immunologically vulnerable site for development of neoplasms.

Authors:  Vincenzo Ruocco; Robert A Schwartz; Eleonora Ruocco
Journal:  J Am Acad Dermatol       Date:  2002-07       Impact factor: 11.527

Review 9.  Vulvovaginal reconstruction for neoplastic disease.

Authors:  Michael Höckel; Nadja Dornhöfer
Journal:  Lancet Oncol       Date:  2008-06       Impact factor: 41.316

Review 10.  Vulvar cancer: epidemiology, clinical presentation, and management options.

Authors:  Ibrahim Alkatout; Melanie Schubert; Nele Garbrecht; Marion Tina Weigel; Walter Jonat; Christoph Mundhenke; Veronika Günther
Journal:  Int J Womens Health       Date:  2015-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.